AJNA BioSciences
PrivateLast Round
Crowdfunding
Oct 9, 2025
Est. Valuation
$126.07M
Total Funding Raised
$12.29M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
AJNA BioSciences operates in Healthcare & Life Sciences and is based in Littleton, Colorado. Its latest recorded funding round was a Crowdfunding round in October 2025.
AJNA BioSciences is a biotechnology company developing FDA-approved botanical pharmaceuticals from plants and fungi to treat central nervous system disorders such as Autism Spectrum Disorder, Generalized Anxiety Disorder, and Post-Traumatic Stress Disorder.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AJNA BioSciences Comparables
Compare AJNA BioSciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Magdalena Biosciences | 81% | |
| Filament Health Corp. | 81% | |
| BRC Therapeutics | 80% |
For institutional investors. Book with your work email.
AJNA BioSciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Oct 9, 2025 | ||||
| Crowdfunding | Apr 29, 2025 | ||||
| Crowdfunding | Oct 11, 2024 | ||||
| Seed | Jun 10, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 63% MoM, from 676 to 1.1K.
- Jul 26, 2026
Monthly visitors grew 39% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 15, 2026
Ajna BioSciences is currently developing a novel cannabinoid treatment for autism spectrum disorder alongside a full-spectrum psilocybin compound entering Phase I clinical trials.
For institutional investors. Book with your work email.
AJNA BioSciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AJNA BioSciences's valuation, stock price, and market status.
Is AJNA BioSciences a public or private company?
AJNA BioSciences is a private company.
What is the current stock price of AJNA BioSciences?
AJNA BioSciences is a private company, so its shares have no public market price. Caplight tracks AJNA BioSciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AJNA BioSciences worth (valuation)?
AJNA BioSciences's valuation is estimated at $126.1M based on funding round data.
Can I buy AJNA BioSciences stock?
AJNA BioSciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AJNA BioSciences's last funding round?
AJNA BioSciences's most recent funding round was Crowdfunding on October 9, 2025.
Who are the main investors in AJNA BioSciences?
Investor information for AJNA BioSciences is not publicly disclosed.
Will AJNA BioSciences IPO soon?
No public IPO plans have been announced for AJNA BioSciences.
How can I track AJNA BioSciences secondary market activity?
Caplight tracks bids, offers, and trades in AJNA BioSciences's shares on secondary markets.